CAMP and infection: Jacobsen et al. showed that hCAP-18/LL-37 adenoviral delivery in infection due to P. aurogonisa after burn wounds could be up to 1,000-fold stronger compared to the therapeutic effect of synthetic LL-37 peptide [51].